9Introduction: Axillary lymph node dissection (ALND) has been considered essential for the staging of breast cancer (BC). As the impact of tumor biology on clinical outcomes is recognized, a surgical de-escalation approach is being implemented. We performed a retrospective study focused on surgical management of the axilla in invasive lobular carcinoma (ILC) versus invasive ductal carcinoma (IDC). Materials and methods: 1151 newly diagnosed BCs, IDCs (79.6%) or ILCs (20.4%), were selected among patients treated at our Breast Cancer Unit from 2012 to 2018. Tumor characteristics and clinical information were collected and predictors of further metastasis after positive sentinel lymph node biopsy (SLNB) analyzed in relation to disease-free sur...
Simple Summary Currently, it is unclear which kind of axillary staging surgery breast cancer patient...
BackgroundThe American College of Surgeons Oncology Group (ACOSOG) Z0011 trial demonstrated no diffe...
AbstractBackgroundInvasive lobular cancer (ILC) is biologically distinct from invasive ductal cancer...
Introduction: Axillary lymph node dissection (ALND) has been considered essential for the staging of...
In patients with invasive lobular carcinoma (ILC) and clinically positive nodes (cN1) who demonstrat...
1. To systematically analyse studies comparing survival outcomes between axillary lymph-node dissect...
Invasive lobular carcinoma (ILC) accounts for 8-14% of all breast cancers and carries distinct progn...
Background and objectives The Axillary Lymph Node Dissection (ALND) is the standard treatment in pat...
The role of axillary surgery for early breast carcinoma treated with conservative surgery and radiot...
AbstractBackgroundIt was observed during dissection of heavy deposits of axillary lymph nodes (LNs) ...
BACKGROUND: The St Gallen 2019 guidelines for primary therapy of early breast cancer recommend omiss...
Background: Sentinel lymph node (SLN) biopsy is the standard of care for axillary staging in invasiv...
The management of the axilla has been the subject of debate for some years. The debate has become ev...
Purpose: The need for performing axillary lymph-node dissection in early breast cancer when the sent...
Simple Summary: Currently, it is unclear which kind of axillary staging surgery breast cancer patien...
Simple Summary Currently, it is unclear which kind of axillary staging surgery breast cancer patient...
BackgroundThe American College of Surgeons Oncology Group (ACOSOG) Z0011 trial demonstrated no diffe...
AbstractBackgroundInvasive lobular cancer (ILC) is biologically distinct from invasive ductal cancer...
Introduction: Axillary lymph node dissection (ALND) has been considered essential for the staging of...
In patients with invasive lobular carcinoma (ILC) and clinically positive nodes (cN1) who demonstrat...
1. To systematically analyse studies comparing survival outcomes between axillary lymph-node dissect...
Invasive lobular carcinoma (ILC) accounts for 8-14% of all breast cancers and carries distinct progn...
Background and objectives The Axillary Lymph Node Dissection (ALND) is the standard treatment in pat...
The role of axillary surgery for early breast carcinoma treated with conservative surgery and radiot...
AbstractBackgroundIt was observed during dissection of heavy deposits of axillary lymph nodes (LNs) ...
BACKGROUND: The St Gallen 2019 guidelines for primary therapy of early breast cancer recommend omiss...
Background: Sentinel lymph node (SLN) biopsy is the standard of care for axillary staging in invasiv...
The management of the axilla has been the subject of debate for some years. The debate has become ev...
Purpose: The need for performing axillary lymph-node dissection in early breast cancer when the sent...
Simple Summary: Currently, it is unclear which kind of axillary staging surgery breast cancer patien...
Simple Summary Currently, it is unclear which kind of axillary staging surgery breast cancer patient...
BackgroundThe American College of Surgeons Oncology Group (ACOSOG) Z0011 trial demonstrated no diffe...
AbstractBackgroundInvasive lobular cancer (ILC) is biologically distinct from invasive ductal cancer...